mRNA metabolism and hereditary disorders: A tale of surveillance and escape

Klinische Padiatrie

Volumn 216, Issue 6, 2004, Pages 304-314

  Neu Yilik, Gabriele ^a,b   Kulozik, A E ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Molecular Medicine Partnership Unit   (Germany)

Author keywords

Hereditary disorders; mRNA; mRNA surveillance; NMD; Therapy

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; GENETIC DISORDER; GENETIC TRANSCRIPTION; INTRON; MOLECULAR GENETICS; OPEN READING FRAME; REGULATORY MECHANISM; REVIEW; RNA METABOLISM; RNA PROCESSING; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

BASE SEQUENCE; EXONS; FEMALE; GENE EXPRESSION; GENETIC DISEASES, INBORN; HUMANS; INTRONS; MALE; MICROARRAY ANALYSIS; MUTATION; POINT MUTATION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 8744279261     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-832337     Document Type: Review

References (65)

1. Bentley D. The mRNA assembly line: transcription and processing machines in the same factory. Curr Opin Cell Biol 2002; 14: 336-342
2. Black C. Switching on gene therapy. PharmaGenomics 2003; 48-52
3. Bracco L, Kearsey J. The relevance of alternative RNA splicing to pharmacogenomics. Trends Biotechnol 2003; 21: 346-353
4. Brais B, Bouchard JP, Xie YG, Rochefort DL, Chretien N, Tome FM, Lafreniere RG, Rommens JM, Uyama E, Nohira O, Blumen S, Korczyn AD, Heutink P, Mathieu J, Duranceau A, Codere F, Fardeau M, Rouleau GA, Korcyn AD. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 1998; 18: 164-167
5. Brinkman BM. Splice variants as cancer biomarkers. Clin Biochem 2004; 37: 584-594
6. Butler JS. The yin and yang of the exosome. Trends Cell Biol 2002; 12: 90-96
7. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002; 3: 285-298
8. Cartegni L, Krainer AR. Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat Struct Biol 2003; 10; 120-125
9. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 2003; 31: 3568-3571
10. Casolari JM, Silver PA. Guardian at the gate: preventing unspliced pre-mRNA export. Trends Cell Biol 2004; 14: 222-225
11. Celotto AM, Graveley BR. Exon-specific RNAi: a tool for dissecting the functional relevance of alternative splicing. RNA 2002; 8: 718-724
12. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002; 99: 13926-13931
13. Cochet O, Heard D, Fehlbaum P, Ducray C, Bracco L. Exploiting human genomic diversity through alternative RNA splicing. PharmaGenomics 2003; 26-36
14. Danckwardt S, Gehring NH, Neu-Yilik G, Hundsdoerfer P, Pforsich M, Frede U, Hentze MW, Kulozik AE. The prothrombin 3′ end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations. Blood 2004; 104: 428-435
15. Edwalds-Gilbert G, Veraldi KL, Milcarek C. Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res 1997; 25: 2547-2561
16. Fairbrother WG, Yeh RF, Sharp PA, Burge CB. Predictive identification of exonic splicing enhancers in human genes. Science 2002; 297: 1007-1013
17. Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev 2003; 17: 419-437
18. Frischmeyer PA, van Hoof A, O'Donnell K, Guerrerio AL, Parker R, Dietz HC. An mRNA surveillance mechanism that eliminates transcripts lacking termination codons. Science 2002; 295: 2258-2261
19. Garcia-Blanco MA, Baraniak AP, Lasda EL Alternative splicing in disease and therapy. Nat Biotechnol 2004; 22; 535-546
20. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, Kulozik AE. Increased efficiency of mRNA 3′ end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet 2001; 28: 389-392
21. Graveley BR. Alternative splicing: increasing diversity in the proteomic world. Trends Genet 2001; 17: 100-107
22. Graveley BR. Sorting out the complexity of SR protein functions. RNA 2000; 6: 1197-1211
23. Hayes GM, Carpenito C, Davis PD, Dougherty ST, Dirks JF, Dougherty GJ. Alternative splicing as a novel of means of regulating the expression of therapeutic genes. Cancer Gene Ther 2002; 9: 133-141
24. Heasman J. Morpholino oligos: making sense of antisense? Dev Biol 2002; 243: 209-214
25. Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 1999; 96: 307-310
26. Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE. Nonsense-mediated decay approaches the clinic. Nature Genetics 2004; 36: 801-808
27. Jensen TH, Dower K, Libri D, Rosbash M. Early formation of mRNP: license for export or quality control? Mol Cell 2003; 11: 1129-1138
28. Jensen TH, Rosbash M. Co-transcriptional monitoring of mRNP formation. Nat Struct Biol 2003; 10: 10-12
29. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003; 302: 2141-2144
30. Keene JD, Tenenbaum SA. Eukaryotic mRNPs may represent posttranscriptional operons. Mol Cell 2002; 9: 1161-1167
31. Kolev NG, Huber PW. VgRBP71 stimulates cleavage at a polyadenylation signal in Vg1 mRNA, resulting in the removal of a cis-acting element that represses translation. Mol Cell 2003; 11: 745-755
32. Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992; 90: 41-54
33. Ladd AN, Cooper TA. Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol 2002; 3: 0008.1-0008.16
34. Liu HX, Cartegni L, Zhang MQ, Krainer AR. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 2001; 27: 55-58
35. rd, Sullenger BA, Byun J. Ribozyme-mediated revision of RNA and DNA. J Clin Invest 2003; 112: 312-318
36. Maniatis T, Reed R. An extensive network of coupling among gene expression machines. Nature 2002; 416: 499-506
37. Mansfield SG, Chao H, Walsh CE. RNA repair using spliceosome-mediated RNAtrans-splicing. Trends Mol Med 2004; 10: 263-268
38. Maquat LE. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nature Reviews Molecular Cell Biology 2004; 5: 89-99
39. Maquat LE. The power of point mutations. Nat Genet 2001; 27: 5-6
40. Maquat LE, Carmichael GG. duality control of mRNA function. Cell 2001; 104: 173-176
41. Matsumoto K, Wassarman KM, Wolffe AP. Nuclear history of a pre-mRNA determines the translational activity of cytoplasmic mRNA. EMBO J 1998; 17: 2107-2121
42. Mercatante DR, Bortner CD, Cidlowski JA, Kole R. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells, analysis of apoptosis and cell death. J Biol Chem 2001; 276: 16411-16417
43. Miyamoto S, Chiorini JA, Urcelay E, Safer B. Regulation of gene expression for translation initiation factor elF-2 alpha: importance of the 3′ untranslated region. Biochem J 1996; 315: 791-798
44. Modrek B, Lee C. A genomic view of alternative splicing. Nat Genet 2002; 30: 13-19
45. Moteki S, Price D. Functional coupling of capping and transcription of mRNA. Mol Cell 2002; 10: 599-609
46. Mukherjee D, Gao M, O'Connor JP, Raijmakers R, Pruijn G, Lutz CS, Wilusz J. The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J 2002; 21: 165-174
47. Nagy E, Maquat LE. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 1998; 23: 198-199
48. Philips AV, Cooper TA. RNA processing and human disease. Cell Mol Life Sci 2000; 57: 235-249
49. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703
50. Proudfoot NJ, Furger A, Dye MJ. Integrating mRNA processing with transcription. Cell 2002; 108: 501-512
51. Rogers CS, Vanoye CG, Sullenger BA, George AL Jr. Functional repair of a mutant chloride channel using a trans-splicing ribozyme. J Clin Invest 2002; 110: 1783-1789
52. Scott J. A place in the world for RNA editing. Cell 1995; 81: 833-836
53. Simmons DL Variants of cyclooxygenase-1 and their roles in medicine. Thromb Res 2003; 110: 265-268
54. Staege MS, Hattenhorst UE, Neumann UE, Mutter C, Foja S, Burdach S. DNA-microarrays as tools for the identification of tumor specific gene expression profiles: applications in tumor biology, diagnosis and therapy. Klin Paediatr 2003; 215: 135-139
55. Summerton JE. Custom cancer therapies: safe and effective treatments for most or all cancers. Ann N Y Acad Sci 2003; 1002: 189-196
56. Thein SL. Genetic insights into the clinical diversity of beta thalassaemia. Br J Haematol 2004; 124: 264-274
57. Vacek M, Sazani P, Kole R. Antisense-mediated redirection of mRNA splicing. Cell Mol Life Sci 2003; 60: 825-833
58. van Hoof A, Parker R. The exosome: a proteasome for RNA? Cell 1999; 99: 347-350
59. Vasudevan S, Peltz SW. Nuclear mRNA surveillance. Curr Opin Cell Biol 2003; 15: 332-337
60. Vinciguerra P, Stutz F. mRNA export: an assembly line from genes to nuclear pores. Curr Opin Cell Biol 2004; 16: 285-292
61. Waggoner SA, Liebhaber SA. Regulation of alpha-globin mRNA stability. Exp Biol Med 2003; 228: 387-395
62. Wagner E, Lykke-Andersen J. mRNA surveillance: the perfect persist. J Cell Sci 2002; 115: 3033-3038
63. Zamaratski E, Pradeepkumar PI, Chattopadhyaya J. A critical survey of the structure-function of the antisense oligo/RNA heteroduplex as substrate for RNaseH. J Biochem Biophys Methods 2001; 48: 189-208
64. Zhang K, Kaufman RJ. Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem 2004; 279: 25935-25938
65. Zhao J, Hyman L, Moore C. Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 1999; 63: 405-445